They are part of the AGORiA SANTĒ consortium
Olivier Nataf, President of AstraZeneca France
"Health data and artificial intelligence technology have the potential to transform our approach towards the treatments of tomorrow and to demonstrate their clinical, economic and organizational value. We invite all operators in the ecosystem to join AGORiA SANTĒ to contribute together to the competitiveness and attractiveness of France in the domain of data usage for improved management of its citizens' health."
Jean-Yves Robin, President of Impact Healthcare
"Data is the first source of innovation for health in the 21st century and AGORiA SANTĒ must contribute to the development of this key sector for the future of healthcare"
Dr Thierry Marquet, Director of Patient Access to Innovation at Takeda France
“Joining AGORiA SANTĒ illustrates Takeda's commitment to producing quality real-life data at a time when the need to supplement clinical trial data is increasingly crucial. We are, in fact, convinced that real-life data is a major challenge for improving existing solutions and accelerating the provision of new health solutions, meeting the needs of patients, professionals and health authorities, not yet. satisfied. Aware that we cannot solve the challenges of accessing and securing health data alone, we are proud to join AGORiA SANTĒ. »